Search
Filter Results
Displaying 801–810 of 832 for “retinal diseases”
-
Dec 17, 2019
First Human Study in US for Induced Pluripotent Stem Cells to be Launched for Advanced Dry AMD
Currently there are no treatments for Advanced Dry AMD, also known as GA, which can lead to significant central vision loss
-
Vision and Eye Health Awareness Calendar
Many different blindness-related awareness campaigns occur throughout the year. Not all of them are coordinated by the Foundation Fighting Blindness; however, we do support efforts to create a greater awareness of blindness.
-
Jul 11, 2019
Gene Therapy Trials for Wet Age-Related Macular Degeneration
After a series of failed trials, current research suggests that the next generation of gene therapies for wet age-related macular degeneration holds promise. Learn how investigators are inducing the body’s cells to administer their own therapeutic response to disease activity.
-
Roster of the Foundation Fighting Blindness Scientific Advisory Board
-
Sep 18, 2018
Apellis Launches Phase 3 Clinical Trial Program for Advanced Dry AMD Treatment
Trial participants will receive intravitreal injections of APL-2, or a sham procedure (placebo), monthly or every other month. The injections are made into the vitreous, the soft gel in the middle of the eye.
-
Aug 7, 2017
Sight and Song: The Christian Guardino Story
Christian Guardino has been singing for as long as he can remember; it’s the seeing that is something new.
-
Jul 19, 2017
Twelve People Receive XLRS Gene Therapy in AGTC's Clinical Trial
AGTC’s gene therapy uses a human-engineered virus — and adeno-associated virus or AAV — to deliver normal copies of retinoschisin to the patient’s retina.
-
Jan 29, 2014
The Power of Suggestion — Challenges of the Placebo Effect
Even in a well-designed clinical trial, the placebo effect can rear its head.
-
Feb 26, 2024
In honor of Age-Related Macular Degeneration (AMD) and Low Vision Awareness Month, we’re highlighting Toni’s story. In her almost eighth decade of life, Toni Mehler has learned to adapt to the unknown, and she draws from those experiences to embrace her diagnosis of AMD.